DNA compared with ADPT: revenue, margins and what each company keeps, and the suppliers and customers both name

DNAGinkgo Bioworks Holdings, Inc.

Mkt capRevenueRevenue

ADPTAdaptive Biotechnologies Corp

Mkt capRevenueRevenue

Compare

DNAGinkgo Bioworks Holdings, Inc.

ADPTAdaptive Biotechnologies Corp

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only DNA 6

TWSTTwistsupplier

—Google Cloudunlistedsupplier

—Virica Biotechunlistedsupplier

—BiomEditunlistedcustomer

2 more · DNA chain ›

Shared 0

No shared counterparties.

Only ADPT 6

PFEPfizercustomer

ILMNIlluminasupplier

—Fred Hutchinson Cancer Research Centerunlistedsupplier

—Genentech

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

unlistedcustomer

2 more · ADPT chain ›

DNAGinkgo Bioworks Holdings, Inc.

9.85▼−12.17%· post 9.90· delayed

Mkt cap$754.9MRevenue$20MQ2 FY26Revenue$150MFY25

ADPTAdaptive Biotechnologies Corp

25.04▼−6.02%· post 25.04· delayed

After hoursNov 2 '26delayed

Mkt cap$4.3BRevenue$72MQ2 FY26Revenue$277MFY25

Compare

After hoursNov 2 '26delayed

DNAGinkgo Bioworks Holdings, Inc.

ADPTAdaptive Biotechnologies Corp

9.85▼−12.17%post 9.90delayed

Price

25.04▼−6.02%post 25.04delayed

$754.9M

Mkt cap

$4.3B

Q2 FY26$20M

Revenue

$72MQ2 FY26

FY25$150M

Revenue

$277MFY25

DNA9.85▼−12.17%vsADPT25.04▼−6.02%After hoursNov 2 '26delayed